Skip to main content

Table 2 Sociodemographic, smoking characteristics and health status of participants (total, intervention, control)a, b

From: WhatsApp embedded in routine service delivery for smoking cessation: effects on abstinence rates in a randomized controlled study

 

Total

Intervention

Control

n

%a

n

%a

n

%a

Gender (n = 132)

 Female

52

39.4

16

36.4

36

40.9

 Male

80

60.6

28

63.6

52

59.1

Age (n = 132)

 18–24

13

9.8

4

9.1

9

10.2

 25–34

41

31.1

12

27.3

29

33.0

 35–44

32

24.2

12

27.3

20

22.7

 45–54

30

22.7

12

27.3

18

20.5

 55+

16

12.1

4

9.1

12

13.6

Marital status (n = 132)

 Not-married

66

50.0

21

47.7

45

51.1

 Married

66

50.0

23

52.3

43

48.9

Education (n = 132)

 Secondary school and below

30

22.7

6

13.6

24

27.3

 High school and above

102

77.3

38

86.4

64

72.7

Social class (n = 117)

 Unemployed

11

9.4

1

2.6

10

12.8

 Blue collar

52

44.4

14

35.9

38

48.7

 White collar

50

42.7

22

56.4

28

35.9

 Self employed

4

3.4

2

5.1

2

2.6

Daily cigarette consumption (n = 132)

  ≤ 10

14

10.6

2

4.5

12

13.6

 11–20

64

48.5

22

50.0

42

47.7

 21–30

32

24.2

14

31.8

18

20.5

  > 30

22

16.7

6

13.6

16

18.2

Pack-years (n = 128)

  ≤ 10

39

30.5

14

32.6

25

29.4

 11–20

42

32.8

15

34.9

27

31.8

  > 20

47

36.7

14

32.6

33

38.8

Quit attempts (n = 132)

 Yes

23

17.4

6

13.6

17

19.3

 No

109

82.6

38

86.4

71

80.7

Nicotine dependence level (n = 132)

 Low

14

10.6

3

6.8

11

12.5

 Medium

89

67.4

30

68.2

59

67.0

 High

29

22.0

11

25

18

20.5

Depression score (n = 130)

 Normal

83

63.8

29

67.4

54

62.1

 High

47

36.2

14

32.6

33

37.9

CO value (n = 132)

 0–6

13

9.8

4

9.1

9

10.2

 7–10

12

9.1

3

6.8

9

10.2

  > 10

107

81.1

37

84.1

70

79.5

Concomitant disease (n = 132)

 No

31

23.5

9

20.5

22

25

 Yes

101

76.5

35

79.5

66

75

Consulting physicians (n = 132)

 A

27

20.5

9

20.5

18

20.5

 B

19

14.4

9

20.5

10

11.4

 C

26

19.7

8

18.2

18

20.5

 D

30

22.7

9

20.5

21

23.9

 E

30

22.7

9

20.5

21

23.9

Pharmacotherapy (n = 131)

 NRT

48

36.6

9

20.9

39

44.3

 Bupropion

22

16.8

9

20.9

13

14.8

 Varenicline

13

9.9

4

9.3

9

10.2

 Combinedb

48

36.6

21

36.6

27

30.7

  1. aColumn percent, b Bupropion + NRT